Acromegaly - 140 Studies Found
Completed |
: Open Label Extension Study Evaluating Safety and Biological Activity of C2L-OCT-01 PR in Acromegalic Patients : Acromegaly : 2008-03-11 : Drug: C2L-OCT-01 PR 30 mg Administered by deep IM (gluteus) on Day 1. Beginning on Day 42, drug injectio |
Completed |
: Efficacy and Safety of C2L-OCT-01 PR in Acromegalic Patients : Acromegaly : 2008-02-04 :
|
Completed |
: Octreotide Efficacy and Safety in First-line Acromegalic Patients : Acromegaly : 2005-09-13 : Drug: Octreotide Other Name: SMS995 |
Completed |
: Study Comparing SOM230 Subcutaneously and Sandostatin Subcutaneously in Acromegalic Patients : Acromegaly : 2004-07-30 : Drug: Pasireotide (SOM230), Octreotide (Sandostatin) |
Completed |
: Sandostatin LAR Depot vs. Surgery for Treating Acromegaly :
: 1999-11-03 : Drug: Sandostatin LAR Depot versus transsphenoidal surgery |
Completed |
: Oral Glucose Tolerance Testing (OGTT) on Patients Taking Somatostatin Analogs : Acromegaly : 2011-06-09 : Other: Oral Glucose Tolerance Test (OGTT) An OGTT is a test that lowers growth hormone in the body to ve |
Completed |
: Safety and Efficacy of Octreotide Long Acting Release (LAR) in Treatment Naïve Acromegalic Patients : Acromegaly : 2005-08-08 : Drug: Octreotide LAR |
Completed |
: Changes of Left Ventricular Mass and Cardiac Function in Patients With Active Acromegaly During Treatment With the Growth Hormone Receptor Antagonist Pegvisomant :
|
Completed |
: Preoperative Lanreotide Treatment in Acromegalic Patients With Macroadenomas : Acromegaly : 2009-10-09 :
|
Completed |
: Sleep Apnea Syndrome on Acromegaly: Impact of the Treatment on the Carbohydrates Metabolism. :
|